SCHEMBL2908251

SCHEMBL2908251

COC(=O)c1cc(-n2c(=O)[nH]cc(F)c2=O)cc(C(C)(C)C)c1OC

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.35
MET P08581 2/20 0.35
AXL P30530 1/20 0.35
HTT P42858 1/20 0.33
HPGD P15428 3/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KDM4E B2RXH2 4/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 3/20 0.32
MEN1 O00255 2/20 0.32
TP53 P04637 1/20 0.32
GAA P10253 2/20 0.32
LMNA P02545 1/20 0.31
MYC P01106 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
NR4A2 P43354 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2913013 0.90 ALDH1A1 (0.33) ALDH1A1METAXLHTTHPGD
SCHEMBL2913339 0.81 ALDH1A1 (0.34) ALDH1A1HPGDCYP3A4KDM4EMAPT
SCHEMBL2913854 0.80
SCHEMBL1530207 0.77 CRBN (0.36) ALDH1A1HPGDCYP3A4SMN1; SMN2KDM4E
SCHEMBL1530145 0.73 CRBN (0.52) ALDH1A1METHPGDKDM4EMAPT
SCHEMBL1530176 0.71 ALDH1A1 (0.31) ALDH1A1HPGD
SCHEMBL2915235 0.70 RARG (0.34) ALDH1A1HPGDKDM4EMAPTGAA
SCHEMBL2908263 0.70 CYP3A4 (0.57) CYP3A4
SCHEMBL2907825 0.70 ALDH1A1 (0.34) ALDH1A1HTTHPGDSMN1; SMN2KDM4E
SCHEMBL1530199 0.70 KDM4E (0.45) ALDH1A1HPGDKDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222646-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C Abbott Laboratories (US) 2010-09-01 EP disclosed
WO-2009039127-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C ABBOTT LABORATORIES (US) 2009-03-26 WO disclosed